| Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies D Planas, T Bruel, L Grzelak, F Guivel-Benhassine, I Staropoli, F Porrot, ... Nature medicine 27 (5), 917-924, 2021 | 729 | 2021 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ... Science translational medicine 12 (559), eabc3103, 2020 | 256 | 2020 |
| Human CD8+ T cell cross-reactivity across influenza A, B and C viruses M Koutsakos, PT Illing, THO Nguyen, NA Mifsud, JC Crawford, S Rizzetto, ... Nature immunology 20 (5), 613-625, 2019 | 204 | 2019 |
| Cluster of COVID-19 in northern France: a retrospective closed cohort study A Fontanet, L Tondeur, Y Madec, R Grant, C Besombes, N Jolly, ... MedRxiv, 2020.04. 18.20071134, 2020 | 202 | 2020 |
| SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation MM Rajah, M Hubert, E Bishop, N Saunders, R Robinot, L Grzelak, ... The EMBO journal 40 (24), e108944, 2021 | 167 | 2021 |
| Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies D Planas, T Bruel, I Staropoli, F Guivel-Benhassine, F Porrot, P Maes, ... Nature communications 14 (1), 824, 2023 | 131 | 2023 |
| Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection N Smith, P Goncalves, B Charbit, L Grzelak, M Beretta, C Planchais, ... Nature immunology 22 (11), 1428-1439, 2021 | 128 | 2021 |
| Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France S Fafi-Kremer, T Bruel, Y Madec, R Grant, L Tondeur, L Grzelak, ... EBioMedicine 59, 2020 | 125 | 2020 |
| SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission A Fontanet, R Grant, L Tondeur, Y Madec, L Grzelak, I Cailleau, ... MedRxiv, 2020 | 99* | 2020 |
| Sex differences in the evolution of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 L Grzelak, A Velay, Y Madec, F Gallais, I Staropoli, C Schmidt-Mutter, ... The Journal of infectious diseases 224 (6), 983-988, 2021 | 92 | 2021 |
| SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors L Grzelak, S Temmam, C Planchais, C Demeret, C Huon, ... MedRxiv, 2020.04. 21.20068858, 2020 | 91 | 2020 |
| Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies J Dufloo, L Grzelak, I Staropoli, Y Madec, L Tondeur, F Anna, S Pelleau, ... Cell Reports Medicine 2 (5), 2021 | 83 | 2021 |
| SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020 A Fontanet, L Tondeur, R Grant, S Temmam, Y Madec, T Bigot, L Grzelak, ... Eurosurveillance 26 (15), 2001695, 2021 | 82 | 2021 |
| Single-cell approach to influenza-specific CD8+ T cell receptor repertoires across different age groups, tissues, and following influenza virus infection S Sant, L Grzelak, Z Wang, M Koutsakos, J Crowe, T Loudovaris, ... Frontiers in immunology 9, 387077, 2018 | 72 | 2018 |
| A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis C de Cevins, M Luka, N Smith, S Meynier, A Magérus, F Carbone, ... Med 2 (9), 1072-1092. e7, 2021 | 48 | 2021 |
| Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA. 1 and BA. 2 C Planchais, I Fernández, T Bruel, GD de Melo, M Prot, M Beretta, ... Journal of Experimental Medicine 219 (7), 2022 | 42 | 2022 |
| Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients THO Nguyen, M Koutsakos, CE van de Sandt, JC Crawford, L Loh, S Sant, ... Nature communications 12 (1), 2691, 2021 | 40 | 2021 |
| Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak L Frumholtz, JD Bouaziz, M Battistella, J Hadjadj, R Chocron, D Bengoufa, ... British Journal of Dermatology 185 (6), 1176-1185, 2021 | 38 | 2021 |
| Human mucosal-associated invariant T cells in older individuals display expanded TCRαβ clonotypes with potent antimicrobial responses L Loh, NA Gherardin, S Sant, L Grzelak, JC Crawford, NL Bird, HF Koay, ... The Journal of Immunology 204 (5), 1119-1133, 2020 | 36 | 2020 |
| Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection N Yatim, J Boussier, P Tetu, N Smith, T Bruel, B Charbit, L Barnabei, ... Science Advances 7 (34), eabg4081, 2021 | 31 | 2021 |
Timothée BruelInstitut PasteurVerified email at pasteur.fr
